Researchers continue to excited about the medication , a innovative dual treatment showing significant results in initial trials for size management. It acts by modulating both systems: GLP-1 and GIP, which , when activated , assist influence cravings and improve calorie burn. Early findings suggest substantial body management and possible improvem